Complimenti.....Sei entrato nel piu' completo Portale sulle Medicine Alternative, Biologico  Naturali e Spirituali - la Guida alla Salute Naturale - Leggi, Studia, Pratica e starai in Perfetta  Salute, senza Farmaci ne' Vaccini

GUIDA  alla  SALUTE con la Natura

"Medicina Alternativa"   per  CORPO  e   SPIRITO
Alternative Medicine"
  for  BODY  and SPIRIT


BIBLIOGRAFIA per la CANDIDA e candidosi

BIBLIOGRAFIA per la Candida - Candida Albicans  
La Bibliografia qui sotto riprodotta e’ cio’ che si puo’ trovare attraverso una ricerca con Google, ma in essa non si trovano soluzioni terapeutiche piu’ complete di quelle qui sopra esposte, in quanto fino ad ora le candidosi sono state poco studiate dalla medicina ufficiale, come cause e concause di importanti patologie.

Dematium albicans (C.P. Robin) Laurent{?}, (1889)
Monilia albicans (C.P. Robin) Zopf, (1890)
Myceloblastanon albicans (C.P. Robin) M. Ota, Japanese Journal of Dermatology and Urology 27: 170 (1927)
Mycotorula albicans (C.P. Robin) Langeron & Talice, Annls Parasit. hum. comp. 10: 44 (1932)
Oidium albicans C.P. Robin, (1853)
Parasaccharomyces albicans (C.P. Robin) Mello & L.G. Fern., (1918)
Procandida albicans (C.P. Robin) E.K. Novák & Zsolt, Acta bot. hung. 7: 133 (1961)
Saccharomyces albicans (C.P. Robin) Reess, (1877)
Syringospora albicans (C.P. Robin) C.W. Dodge, (1935)

Francesco Baciga, Cure naturali della Candida e delle altre infezioni vaginali.
Edizioni Demetra.
Bernard Jensen, Intestino libero.
Macro Edizioni, Cesena (FO). Tel. 0547-346.290.

el-Maghrabi EA. Dixon DM. Burnett JW., Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherance to keratinocytes. Clinical Experimental Dermatology. 15: 3, 183-91, May 1990.
Noah PW. The role of microorganisms in psoriasis. Semin Dermatology. 9:4, 269-76, Dec 1990.
Meinhof W., Intestinal colonization with Candida albicans and its effect on chronic inflammatory dermatoses. German. Hautarzt. 46:8, 525-7, Aug 1995.
Buslau L. Hanel M. Holzmann H., The significance of yeasts in seborrheic eczemna. Hautarzt. 40(10):611-3, Oct. 1989. - German.
Henseler T., Mucocutaneous candidiasis in patients with skin diseases. German. Mycoses. 38 Supplement 1:7-13, 1995.
F. Sabatelli, R. Patel, P.A. Mann, C.A. Mendrick, C.C. Norris, R. Hare, D. Loebenberg, T.A. Black, P.M. McNicholas, (2006). In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole and amphotericin B against a large collection of clinically important molds and yeast. Antimicrob Agents Chemoter. 50(6):2009-2015.
X. Li, N. Brown, A.S. Chau, J.L. Lopez-Ribot, M.T .Ruesga, G. Quindos, C.A. Mendrick, R. Hare, D. Loebenberg, B. DiDomenico, P.M. McNicholas, (2004). Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother. 53:74-80.
M.A. Pfaller, D.J. Diekema, D.J. Sheehan, (2006). Interpretative breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev. 19(2):435-447.
R.F. Boyd, (1992). Microbiologia generale, seconda edizione italiana. Ed. Medical books. Cap.28:929-932.
M. La Placa, (2005). Principi di microbiologia medica, decima edizione. Ed. Società editrice Esculapio. Cap.41:413-414.
B.D. Davis, R. Dulbecco, H.N. Eisen, H.S. Ginsberg, (1995). Microbiologia, quarta edizione. Ed. Zanichelli. Cap.43:779-780. Naglik, J. R., S.J. Challacombe, B. Hube, (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol. 67:400-428.
F. Clementi, G. Fumagalli, R. Paletti, S. Nicosia, (2006). Farmacologia generale e molecolare, terza edizione. Ed. UTET. Cap.43:654-656.
A.J. Ullmann, O.A. Cornely, A. Burchardt, R. Hachem, D.P. Kontoyiannis, K. Töpelt, R. Courtney, D. Wexler, G. Krishna, M. Martinho, G. Corcoran, I. Raad, (2006). Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemoter. 50(2):658-666.
T.J. Walsh, I. Raad, T.F. Patterson, P. Chandrasekar, G.R. Donowitz, R.E. Greene, R. Hachem, S. Hadley, R. Herbrecht, A. Langston, A. Louie, P. Ribaud, B.H. Segal, D.A. Stevens, J.A.H. van Burik, C.S. White, G. Corcoran, J. Gogate, G. Krishna, L. Pedicone, G. Hardalo, J.R. Perfect, (2007). Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis. 44:2-12.
National Committee for Clinical Laboratory Standards, (2002), Reference method for broth diluition antifungal susceptibility testing of yeasts; Approved standard-Second edition. NCCLS document M27-A2. Wayne, PA. 22 n°15.
C. Gil-Lamaignere, R. Hess, S. Salvenmoser, K. Heyn, R. Kappe, F.M.C. Müller, (2005). Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. J Antimicrob Chemother. 55:1016-1019.Fine modulo
Iwata, K.; Yamamoto, Y. Glycoprotein Toxins Produced by Candida albicans. Proceedings of the Fourth International Conference on the Mycoses, PAHO Scientific Publication #356, June 1977.
Quiralte, J.; Blanco, C.; Esparaza, R.; Castillo, R. Carrillo, T. Nasal Candidiasis in an Immunocompetent Patient. Allergologia et Immunopathologia. 21(6):227-8, 1993 Nov.-Dec.
Magnavita, N. Mucocutaneous candidiasis in exposure to biological agents: a clinical case. Medicina del Lavoro. 84(3):243-8, 1993 May-Jun. (in Italiano)
Gutierrez, J.; Maroto, C.; Piedrola, G.; Martin, E.; Perez, JA. Circulating Candida antigens and antibodies: useful markers of candidemia. Journal of Clinical Microbiology. 31(9):2550-2, 1993 Sep.
Walsh, TJ.; Lee, JW.; Sien, T.; Schaufele, R.; Bacher, J.; Switchenko, AC.; Goodman, TC.; Pizzo, PA. Serum D-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. Journal of Medical & Veterinary Mycology. 32(3):205-15, 1994.
Switchenko, AC. Miyada, CG. Goodman, TC. Walsh, TJ. Wong, B. Becker, MJ Ullman, EF. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. Journal of Clinical Microbiology. 32(1):92-7, 1994 Jan.
Hussain, G.; Galahuddin, N.; Ahmad, I.; Galahuddin, I.; Jooma, R. Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. European Journal of Radiology. 20(2):151-5, 1995 Jul.
Cater, RE., 2nd Chronic candidiasis as a possible etiological factor in the chronic fatigue syndrome. Medical Hypotheses. 44(0):507-15 Jun. 1995
Crook, WG. The Yeast Connection Professional Books, Jackson Tennessee
Crook, WG. The Yeast Connection and the Woman. Professional Books, Jackson Tennessee
Di Maio E, M.D. Ayurveda contro i disturbi della donna. Silhouette, 3D Editoriale, Anno 5°, Numero 4, Aprile 1998, Milano .
Di Maio E, M.D. Reiki, Ayurveda, alimentazione ed altro. Puntoluce, Anno 11°, Numero 41, Primavera 1998, Milano.
Di Maio E, M.D. Rivista Mensile "FOCUS" n. 80 del Giugno 1999, Mondadori
Di Maio E., M.D. Rivista Settimanale "GRAZIA" n. 14 del 10  Aprile 2001, Mondadori
Di Maio E, M.D. Come diagnosticare le infezioni da Candida albicans. Polizia Sanitaria, DCB, Anno 12°, Numero 75, 2004, Milano
Widder, RA.; Bartz-Schmidt, KU.; Geyer, IL.; Brunner, R.; Kirchhof, B.; Donike, M.; Ileinmann, K. Candida albicans endophthalmitis after anabolic steroid abuse (letter). Lancet. 345(8945):330-1, 1995 Feb 4.
Ross, VE.; Baxter, DL. Widespread Candida Folliculitis in a Nontoxic Patient. Cutis. 49(1):241-243, 1992 April.
Cater, RE. Somatization disorder and the chronic candidiasis syndrome: a possible overlap. Medical Hypotheses. 35:126-135, 1991.
Kroker, GF. Chronic Candidiasis and Allergy. In: Brosteff J.; Challacombe SJ.;eds. Food Allergy and Intolerance. London:Baillierre Tindall, 1989: ch. 49.
Kirkpatrick, CH.; Smith, TK. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Annals of Internal Medicaine. 80: 310-320, 1974.
Dismukes, WE., Way, JS., Lee, JY., Dockery, B.K., Hain, J.D., A randomized double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. New England Journal of Medicine. 323:1717-23, 1990.
Bennett, JE. Searching for the yeast connection. New England Journal of Medicine. 323:1766-67, 1990.
Zwerling, MH., Owens, KN., Ruth, NH. Think yeast-the expanding spectrum of candidiasis. Journal of the South Carolina Medical Association. 80:454-456, 1984.
Mangani V.,Panfili A., Candida l'epidemia silenziosa:allergia al XX secolo? ed.Tecniche Nuove 1996.
Mangani V.,Panfili A.,La dieta ph ed.       Tecniche Nuove 1997.
Panfili A., Medicina Ortomolecolare.ed Tecniche Nuove 1994
Truss, CO. The role of candida albicans in human illness. Journal of Orthomolecular Psychology. 10:228-238, 1981.
Truss, CO. Tissue injury induced by candida albicans. Journal of Orthomolecular Psychology. 7(1)
Truss, CO. Restoration of immunologic competence to candida albicans. Journal of Orthomolecular Psychology. 9(4)
Truss, CO. Metabolic abnormalities in patients with chronic candidiasis: the acetaldehyde hypothesis. Journal of Orthomolecular Psychology. 13(2):66-93
Bodey, G., Fainstein, V., Garcia, I., Rosenbaum, B., Wong, Y. Effect of broad-spectrum cephalosporins on the microbial flora of recipients. The Journal of Infectious Diseases. 148:892-897, 1983.
Giuliano, M., Barza, M., Jacobus, N., Gorbach, S. Effect of broad spectrum antibiotics on composition of intestinal microflora of humans. Antimicrobial Agents and Chemotherapy. 202-206, 1987.
Gracey, M., Burke, V., Thomas, J. Stone, D. Effect of microorganisms isolated from the upper gut of malnourished children on intestinal sugar absorption in vivo The American Journal of Clinical Nutrition. 28:841-845, 1975.
Eras, P., Goldstein, M., Sherlock, P. Candida infection of the gastrointestinal tract. Medicine 51(5):367-379, 1972.
Trowbridge, J.P., Walker, M. The Yeast Syndrome. Bantam Books. New York, 1986.
Hotopf, Matthew. Seasonal affective disorder, environmental hypersensitivity and somatisation. British Journal of Psychiatry. 164: 246-248, Feb. 1994.
Keith, Sehnert W. Candida-related complex (CRC), a complicating factor in treatment and diagnostic screening for alcoholics: A pilot study of 213 patients. International Journal of Biosocial and Medical Research. 13(1):67-76, 1991.
Rogers, Sherry A. Healing from the inside out: The leaky gut syndrome. Let's Live. 63(4):34-38, Apr 1995.
Neuro-Immunophysiology of the Gastrointestinal Mucosa. Annals of the New York Academy of Sciences. 664, 1992
Shorter, RB. Kirsner, JB. Gastrointestinal Immunity for the Clinician. Grune & Stratton, Inc., Orlando, FL. 1985
Murray, F. Acidophilus fights fungal infections. Better Nutrition for Today's Living. 56(5):54-55, May 1994
Palmer, CA. A yeast for all reasons or is candidiasis the hidden enemy? Nutrition Today. 28(3)24-29, May 1993
Yeast can destroy friendly bacteria. USA Today: The Magazine of the American Scene. 122(2585):6-7, Feb. 1994
Hentges, David J. Human intestinal microflora in health and disease. Academic Press: NY, 1983
Hill, MJ. Role of gut bacteria in human toxicology and pharmacology. Taylor & Francis: Bristol, PA, 1995.
Rowland, IR. Role of the gut flora in toxicity and cancer. Academic Press:San Diego, 1988
Brostoff, J. Challacombe, SJ. Food Allergy and Intolerance. Bailliere Tindall: Philadelphia.
Winner, HI. Hurley, R. Symposium on Candida Infections. E & S Livingstione LTD: London, 1966
James, J. Warin, RP. An assessment of the role of Candida albicans and food yeasts in chronic urticaria. British Journal of Dermatology. 84:227-237, 1971
Schinfeld, JS. PMS and candidiasis: study explores possible link. The Female Patient. 12:July 1987
Witkin, SS. Defective immune response in patients with recurrent candidiasis. Infections in Medicine. May-June 1985
Resseger, Charles S., D.O. or Norwalk, OH. Conversations with
Giannela, RA. Broitman SA. Zamcheck, N. Influence of gastric acidity on bacterial and parasitic enteric infections: a perspective. Annals of Internal Medicine. 78: 271, 1973
Gordon, JE. Chitkara, ID. Wyon, JB. Weanling diarrhea. American Journal of Medical Science. 245:345, 1963
Mackowiak PA. The Normal Microbial Flora. New England Journal of Medicine. 307:83, 1982
Freter, R. Interactions between mechanisms controlling the intestinal microflora. American Journal of Clinical Nutrition. 27:1409, 1974
Bartlett, JG. Antibiotic associated pseudomembranous colitis. Rev Infect Dis. 1:123, 1979
Freter, R. Brickner, H. Botney, M. et al. Mechanisms that control bacterial populations in continuous flow culture models of mouse large intestinal flora. Infectious Immunology. 39:676, 1983
Shedlofsky, S. Freter, R. Synergism between ecologic and immunologic control mechanisms of intestinal flora. Journal of Infectious Diseases. 137:661, 1978
Renfro, L. Feder, HM Jr. Lane, TJ. Manu, P. Matthews, DA. Yeast connection among 100 patients with chronic fatigue. American Journal of Medicine. 86(2):165-8, Feb. 1989.
Schlossberg, D. Devig, PM. Travers, H. Kovalcik, PJ Mullen, JT. Bowel perforation with candidiasis. Journal of the American Medical Association. 238(23):2520-1, Dec 5, 1977.
Schwartz, RH. Knerr, RJ. Candida esophagitis during treatemnt for adolescent acne vulgaris. Pediatric Infectious disease. 1(5):374, Sep-Oct, 1982.
Jayagopal, S. Cervia, JS. Colitis due to Candida albicans in a patient with AIDS. Clinical Infectios Diseases. 15(3):555, Sep. 1992.
Minoli G. Terruzzi V. Butti G. Frigerio G. Rossini A. Gastric candidiasis:an endoscopic and histological study in 26 patients. Gastrointestinal endoscopy. 28(2)59-61, 1982.
Tortora, G. Funke, B. Case, C. Microbiology. New York: Benjamin/Cummings Publishing Company, 1995.
Saltarelli, Cora G. Candida albicans: The Pathogenic Fungus. Hemisphere Publishing Company: Philadelphia, 1989.
Segal, Esther; Baum, Gerald L. Pathogenic Yeasts and Yeast Infections. CRC Press: Ann Arbor, 1994.
Jenzer, Martin, M.D. or Rochester, NY. Conversations with.
Nelson, Robert S. Bruni, Hamilton C. Goldstein, Harvey M. Primary gastric candidiasis in uncompromised subjects. Gastrointestinal Endoscopy. 22:2, 92-94, 1982.
Chan, Stephen, PhD, of SUNY College at Brockport, NY. Conversations with.
Discussions with patients that have been treated with antifungal and diet therapy.

Candida e Psoriasi in Patologia Dermatologica
Skinner, RB. Jr. Rosenberg, W. Noah, PW. Psoriasis of the palms and soles is frequently associated with oropharyngeal Candida albicans. Acta Dermatological Venereol Supplement. 186:149-150, 1994.
M buslau, Menzel I, Holzmann H. Fungal flora of the human faeces in psoriasis and atopic dermatitis. Mycoses. 33:2, 90-4, Feb. 1990.
Soyeur U. Kilic H. Alpan O. Anti-Candida antibody levels in psoriasis vulgaris. Cent. Afr. Journal of Medicaine. 36: 8, 190-2, Aug. 1990.
Baker BS. Powles AV. Malkani AK. Altered call-medicated immunity to group A haemolytic atreptococcal antigens in chronic plaque psoriasis. British Journal of Dermatology. 125: 1, 38-42, Jul 1991.
el-Maghrabi EA. Dixon DM. Burnett JW. Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherance to keratinocytes. Clinical Experimental Dermatology. 15: 3, 183-91, May 1990.
Senff H. Bothe C. Busacker J. Reinel D. Studies on the yeast flora in patients suffering from psoriasis capillitii or seborrheic dermatitis of the scalp. Mycoses. 33:1, 29-32, Jan 1990.
Orkin VF. [The characteristics of the clinical picture of candidiasis of the skin and mucous membranes in patients with chronic dermatosis] - Russian. Vrach Delo. 5, 78-80, May 1992.
McKay M. Vulvar dermatoses: common problems in dermatological and gynecological practice. British Journal of Clinical Pract. Sym. Supplement. 71: 5-10, Sep 1990.
Noah PW. The role of microorganisms in psoriasis. Semin Dermatology. 9:4, 269-76, Dec 1990.
Haneke E. Fungal infections of the nail. Semin Dermatology. 10: 1, 41-53, Mar 1991.
Rosenberg, EW. Noah PW. Skinner RB. Microorganisms and psoriasis. Journal of the National Medical Association. 86:4, 305-10, Apr 1994.
Meinhof W. [Intestinal colonization with Candida albicans and its effect on chronic inflammatory dermatoses]-German. Hautarzt. 46:8, 525-7, Aug 1995.
Buslau L. Hanel M. Holzmann H. The significance of yeasts in seborrheic eczemna. Hautarzt. 40(10):611-3, Oct. 1989. - German
Henseler T. [Mucocutaneous candidiasis in patients with skin diseases] - German. Mycoses. 38 Supplement 1:7-13, 1995.
Kemeny L. Ruzicka T. Dobozy A. Michel G. Role of interleukin-8 receptor in skin. International Archives of Allergy and Immunology. 104: 4, 317-22, Aug 1994.
Squiquera L. Galimberti R. Morelli L. Plotkin L. Milicich R. Kowalckzuk A. Leoni J. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clinical Experimental Dermatology. 19: 4, 289-93, Jul 1994.
Oranje AP. Dzoljic-Danilovic G. Michel MF. Aarsen RS. van Joost, T. [Is juvenile seborrheic dermatitis a candidiasis? Studies of a possible link with microbial infections.] - German Tijdschrift voor Kindergeneeskunde. 55(3):87-92, Jul 1987.

Candida e Diarrea
Burke, V., Gracey, M. An experimental model of gastrointestinal candidiasis Journal of Medical Microbiology. 13:103-110.
Gupta, T., Ehrinpreis, M. Candida-associated diarrhea in hospitalized patients. Gastroenterology. 98:780-785, 1990.
Danna, P., Urban, C., Bellin, E., Rahal, J. Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. The Lancet. 337:511-514, 1991.
Bishop, R., Barnes, G. Depression of lactase acitivity in the small intestines of infant rabbits by Candida albicans.
Kane, J., Chretien, J., Garagusi, V. Diarrhoea caused by Candida The Lancet. 335-336, 1976. (Immunocompetent).
Garagusi, VF. Chretien, JH. Diarrhoea caused by Candida.(letter) Lancet. 1(7961):697-8, Mar 27, 1976.
Letter in Lancet in response. Enweani IB. Obi CL. Jokpeyibo M. Prevalence of Candida species in Nigerian children with diarrhoea. J.Diarrhoeal Dis Res 12(2):133-5, Jun, 1994.
Gut flora in normal and disordered states. Chemotherapy. 5-15, 1995.
Vogel LC. Antibiotic-induced diarrhea. Orthop Nurs 14(2): 38-41, Mar-Apr, 1995.
Koffi-Akoua G. Ferly-Therizol M. Kouassi-Beugre MT. Konan A. Timite AM. Assi Adou J. Assale G. [Cryptosporidium and candida in pediatric diarrhea in Abidjan.] Bull Soc Pathol Exot Filiales 82(4): 451-7, , 1989.
Ngan PK. Khanh NG. Tuong CV. Quy PP. Anh DN. Thuy HT. Persistent diarrhea in Vietnamese children: a preliminary report. Acta Paediatric Supplement. 381: 124-6, Sep, 1992.
Siregar CD. Sinuhaji AB. Sutanto AH. Spectrum of digestive tract diseases 1985-1987 at the Pediatric Gastroenterology Outpatient Clinic of Dr. Pirngadi General Hospital, Medan. Paediatr Indones. 30(5-6): 133-8, May-Jun, 1990.
Talwar P. Chakrabarti A. Chawla A. Mehta S. Walia BN. Kumar L. Chugh KS. Fungal diarrhoea: association of different fungi and seasonal variation in their incidence. Mycopathologia. 110(2): 101-5, May, 1990.
Omoike IU. Abiodun PO. Upper small intestinal microflora in diarrhea and malnutrition in Nigerian children. Journal of Pediatric Gastroenterolog Nutrition 9(3): 314-21, Oct, 1989.

Hirschel B. [AIDS and gastrointestinal tract: a summary for gastroenterologists and surgeons] Schweiz Med Wochenschr. 120(14): 475-84, Apr 7, 1990.
Gage TP. Eagan J. Gagnier M. Diverticulitis complicated by candidal pylephlebitis. South Med. Journal 78(10): 1265-6, Oct, 1985.
Caselli M. Trevisani L. Bighi S. Aleotti A. Balboni PG. Gaiani R. Bovolenta MR. Stabellini G. Dead fecal yeasts and chronic diarrhea. Digestion. 41(3): 142-8, 1988.
Zhen DL. [Analysis of the causative organisms in adult acute infectious diarrhea encountered in the past 12 years]. Chung Hua Nei Ko Tsa Chih 21(9): 540-2, Sep, 1982.
Lorenz A. Grutte FK. Schon E. Muller B. Klimmt G. [Fungal infection of the small bowel mucosa.] Mykosen. 27(10): 506-10, Oct, 1984.

Candida ed Antibiotici
[Clinical evaluation of a new oral penem, SY5555, in the pediatric field.] Japanese Journal of Antibiotics. 41-8, Jan, 1995.
Elmer GW. Surawicz CM. McFarland LV. Biotherapeutic agents: A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. Journal of the American Medical Association. 275(11): 870-6, Mar 20, 1996.

(1) I. Al-Mohsen, W.T. Huges, Systemic antifungal therapy:past present and future (1997).
(2) Z.K. Khan e P.Jain, Antifungal agents and Immunomodulators in systemic mycoses (2000), Ind.J.Chest Diseases and Allied Sciences, 42,4.
(3) Nafsika H. Georgopapadakou, Update on antifungals targeted to the cell wall:focus on ß-1,3-glucan synthase inhibitors. Exp. Opin. Invest. Drugs, (2001),10(2).
(4) Cancidas, product Highlights, Merk&Co.,Inc., Whitehouse station, NJ08889,USA.
(5) J.P. Gaughran, M.H.Lai,et al., Nikkomycin Z is a specific inhibitor of S.cerevisiae chitin synthase Chs3 in vitro e in vivo; J. Of Bacteriology, 1994, 5857-5860.
(6) Nafsika H. Georgopapadakou, Current Opinion in Microbiology, 1998, 1:547-557.
(7) Ram A. F. J., Kapteyn J. C., et al. ; Loss of the plasma membrane-bound protein Gas1 in S.cerevisiae. (1998). J. Bacteriol., 180:1-7.
(8) L. Popolo, T. Gualtieri, E. Ragni, The yeast cell wall salvage pathway (2001) , Med.Mycol.39, Suppl 1, 111-21.
(9) A. Lagorce, N.C.Hauser, et al ; Genome wide analysis of the response to cell wall mutations in the yeast S.cerevisiae, (2003). J. Biol. Chem.,278 :20345-20357.
(10) T. Ketela, R. Green e H. Bussey, S.cerevisiae mid2p is a potential cell wall stress sensor. (1999), J. Bacteriology, 181:3330-3340.
(11) M.C.Cruz, A.L.Goldstein et al., Calcineurin is essential for survival during membrane stress in C.albicans. EMBO J., 2002, 21,4:546-559.
(12) M. Karababa, A.T. Coste et al, Comparison of gene expression profiles of C.albicans azole resistant clinical isolates. Antimicrobial Agents and Chemiotherapy, 2004: 3064-3079.
(13) Molina M., Gil C., Pla J., Arroyo J. e Nombela C. (2000). Protein localization approches for understanding yeast cell wall biogenesis. Microsc. Res. Tech., 51: 601-612.
(14) N.H.Georgopapadakou e J.S. Tkacz, The fungal cell wall as a drug target. Trends in microbiolology, 1995, 98,3.
(15) Manners D.J., Masson A.J. e Patterson J.C. The structure of a beta-(1 leads to 3)-D-glucan from yeast cell walls (1973). Biochem. J., 135: 19-30.
(16) Kollar R., Reinhold B., Petrakova E., et al. Architecture of the yeast cell wall. (1997). J. Biol. Chem., 272:17762-17775.
(17) Stokke B. T., Elgsaeter A., Hara C., Kitamura S. e Takeo K. Physicochemical properties of (1-->6)-branched (1-->3)-beta-D-glucans. 1. Physical dimensions estimated from hydrodynamic and electron microscopic data (1993). Biopolymers, 33:561-573.
(18) Lipke P. N., e Ovalle R. (1998). Cell wall architecture in yeast:new structure and new challenges. J.Bacteriol., 180: 3735-3740.
(19) Kapteyn J. C., Montijin R. C., Dijkgraaf G. J. P., Van den Ende H., e Klis F. M. Covalent association of beta-1,3-glucan with beta-1,6-glucosylated mannoproteins in cell walls of Candida albicans. (1995). J. Bacteriol., 177: 3788-3792.
(20) Kapteyn J. C., Ram A. F., Groos E. M., Kollar R., Montijin R. C., Van den Ende H., Llobell A., Cabib E., e Klis F. M. Altered extent of cross-linking of beta1,6-glucosylated mannoproteins to chitin in Saccharomyces cerevisiae mutants with reduced cell wall beta1,3-glucan content (1997). J. Bacteriol., 179: 6279-6284.
(21) Kollar R., Petrakova E., Ashwell G., et al. Architecture of the yeast cell wall. (1995). J. Biol. Chem., 270:1170-1178.
(22) Eng W. K., Faucette L., McLaughlin M. M., Cafferkey R., Koltin Y., Morris R. A., Young P. R., Johnson R. K. e Livi G. P. The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth (1994). Gene, 151: 61-71.
(23) Mazur P., Morin N., baginsky W., El-Sherbeini M., Clemas J.A.,Nielsen J. B. e Foor F. Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase (1995). Mol. Cell. Biol., 15: 5671-5681.
(24) Goldman R., Sullivan P.A., Zakula D., Capobianco J. O. Kinetics of beta-1,3 glucan interaction at the donor and acceptor sites of the fungal glucosyltransferase encoded by the BGL2 gene. (1995). Eur. J. Biochem., 227: 372-378.
(25) Boone C., Sommer S. S., Hensel A. e Bussey H. Yeast KRE genes provide evidence for a pathway of cell wall beta-glucan assembly (1990). J. Cell. Biol., 110: 1833-1843.
(26) Klis F. (1994). Dinamic of cell wall structure in S.cerevisiae. Yeast, 10: 851-869
(27) Orlean P. (1997). '' The molecular and cellular biology of the yeast Saccharomyces, vol. 3. Cell cycle and cell biology''. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y..
(28) Cabib E., Shaw J., Mol P., Bowers B. e Choi W. (1996). Biochemestry and Molecular Biology, p. 243-267. In Brambl and Marzluf (ed.), The mycota III.
(29) Bulawa C. E., Slater M., et al, CSD2, CSD3 and CSD4, genes required for chitin synthesis in S.cerevisiae. (1986). Cell, 46: 213-225.
(30) Chuang J., Schekman R. Differential trafficking and timed localization of two chitin synthase proteins, Chs2p and Chs3p. (1996). J. B. C., 135: 597-610.
(31) Kapteyn J. C., Van Egmond P., Sievi E., Van den Ende H., Makarow M. e Klis F. M. The cell wall architecture of C.albicans wild type cells and cell-wall defective mutants (1999). Mol. Microbiol., 31: 1835-1844.
(32) Smits G. J., Kapteyn J., Van Den Ende H. e Klis F. Cell wall dynamics in yeast (1999). Curret Opinion in Cell Biology, 2: 348-352.
(33) Popolo L. e Alberghina L., Identification of a labile protein involved in the G1-to-S transition in S.cerevisiae.(1984). Proc. Natl. Acad. Sci. USA., 81: 120.
(34) Popolo L., Vai M. e Alberghina L., Identification of a glycoprotein involved in cell cycle progression in yeast (1986). J. Biol. Chem. 261: 3479.
(35) Conzelmann A., Riezman H., Desponds C. e Bron C. A major 125-kd membrane glycoprotein of Saccharomyces cerevisiae is attached to the lipid bilayer through an inositol-containing phospholipid. (1988). EMBO J., 7: 2233-2240.
(36) Ram A. F. J., Brekelmans S. S. C., Oehlen B. J. W. M. e Klis F. M. Cell wall architecture in yeast.(1995). FEBS Lett. 358: 165-170.
(37) Lussier M., White A. M., Sheraton J. e al. Dinamic of the cell wall structure. (1997). Genetics, 147: 435-450.
(38) Popolo L. e Vai M. The Gas1 glycoprotein, a putative wall polymer cross-linker (1999). Biochem. et Biophys. Acta, 1426: 385-400.
(39) Mouyna I., Fontaine T., Vai M., et al, Glycosylphospatidylinositol-anchored glucanosyltransferases play an active role in the biosynthesis of the fungal cell wall. (2000b). J. Biol. Chem., 275 (20): 14882-14889.
(40) Popolo L., Grandori R., Vai M., Lacanà E. Alberghina L. Immunochemical characterization of gp115, a yeast glycoprotein modulated by the cell cycle. (1988). Eur. J. Coll. Biol., 47 : 173.
(41) Vai M., Popolo L., Grandori R., Lacanà E. e Alberghina L. The cell cycle modulated glycoprotein GP115 is one of the major yeast proteins containing glycosylphosphatidylinositol (1990). Biochem. Biophys. Acta, 1038: 227.
(42) Vai M., Gatti E., Lacanà E., Popolo L. e Alberghina L. Isolation and deduced amino acid sequence of the gene encoding gp115, a yeast glycophospholipid-anchored protein containing a serine-rich region (1991). J. Biol. Chem., 260: 12242.
(43) Gatti E., Popolo L., Vai M., Rota N. e Alberghina L. O-linked oligosaccharides in teast GPI-anchored protein gp115 are clustered in a serine rich region not essential for its function (1994). J. Biol. Chem., 269 (31): 19695-19700.
(44) de Sampaio G., Bourdineaud J. P. e Lauquin G. J. M. A constitutive role for GPI anchors in S.cereviasiae:cell wall targeting (1999). Mol. Microbiol., 34(2): 247-256.
(45) Conzelmann A., Puoti A., Lester R. L. e Desponds C. Two different types of lipid moieties are present in glycophosphoinositol-anchored membrane proteins of Saccharomyces cerevisiae. (1992) EMBO J., 9: 653.
(46) Nuoffer C., Jeno P., Conzelmann A. e Riezmann H. Determinants for glycophospholipid anchoring of the Saccharomyces cerevisiae GAS1 protein to the plasma membrane. (1991). Mol. Cell. Biol., 11: 27.
(47) L.H.P. Caro, H. Tettelin, et al, In silicio identification of GPI-anchored plasma-membrane and cell wall protein of S.cerevisiae. Yeast (1997),13:1477-1489.
(48) M.B. Frieman and B.P. Cormack, Multiple sequence signals determine the distribution of GPI-proteins between the plasma membrane and cell wall in S.cerevisiae. Microbiology (2004),150:3105-3114.
(49) Vanoni M., Vai M., Morrione A., Venturini M., Lacanà E., Rossini D., Martegani E., Popolo L. e Alberghina L. (1994). Proceedings 16th European Congress Of Biotechnology, 4: 4-13.
(50) Qing Yuan Yin, P.W.J. de Grott et al, Comprehensive proteomic analysis of S.cerevisiae cell walls. J. Biol. Chem. (2005),21 :20894-20901.
(51) P. Barral, batanero E. et al, A major allergen from pollen defines a novel family of plant proteins and shows intra- and interspecie cross-reactivity. J. Immunology (2004),3644-3651.
(52) P.Barral, C.Suarez et al, An olive pollen protein with allergenic activity, Ole e 10, defines a novel family of CBMs. Biochem. J., May 2005.
(53) Vai M., Orlandi I., Cavadina P., Alberghina L. e Popolo L. C.albicans homologeu of GGP1/GAS1 gene is functional in S.cerevisiae and contains the detrminants for GPI attachment(1996). Yeast, 12: 361-368.
(54) Rodriguez R., Villalba M., Monsalve R. I. e Batanero E. The spectrum of olive pollen allergens. (2001). Int. Arch. Allergy Immunol., 125: 185-195.
(55) Hartland R. P., Fontaine T., Debeaupuis J. P., Simenel C., Delepierre M. e Latgé J. P. A novel beta-1,3-gluanosyltransferase from the cell wall of A.fumigatus. (1996). J. Biol. Chem., 271(43): 26843-26849.
(56) Popolo L., Cavadini P., Vai M. e Alberghina L. Transcript accumulation of the GGP1 gene, encoding a yeast GPI-anchored glycoprotein, is inhibited during arrest in the G1 phase and during sporulation (1993). Curr. Genet., 24: 382-387.
(57) Popolo L., Girardelli D., Bonfante p. e Vai M. Increase in chitin as an essential response to defects in assembly of cell wall polymers in ggp1delta mutant of S.cerevisiae (1997). J. Bacteriol. 179: 463-469.
(58) De Nobel H., Ruiz C., Martin H., Morris W., Brul S., Molina M. e Klis F M. Cell wall perturbation in yeast results in dual phosphorylation of the Slt2/Mpk1 MAP kinase and in an Slt2-mediated increase in FKS2-lacZ expression, glucanase resistance and thermotolerance (2000). Microbiology, 146:2121-2132.
(59) Muhlschlegel F. A. e Fonzi W. A. PHR2 of Candida albicans encodes a functional homolog of the pH-regulated gene PHR1 with an inverted pattern of pH-dependent expression. (1997). Mol. Cell. Biol., 17:5960-5967.
(60) Ghannouum M. A., Spellgerg B., Saporito-Irwin S. M. e Fonzi W. A. Reduced virulence of C.albicans PHR1 mutants (1995). Infect. Immun., 63:4528-4530.
(61) Saporito-Irwin S. M.PHR1, a pH regulated gene of C.albicans, is required for morfogenesis. (1995) Mol.Cell Biol., 15:601-613.
(62) Popolo L. e Vai M. Defects in assembly of the extracellular matrix are responsible for altered morfogenesis of C.albicans phr1 mutant. (1998). J. Bacteriol., 179:463-469.
(63) Fonzi W. A. PHR1 and PHR2 of C.albicans encode putative glycosidases required for proper cross-linking of beta-1,3 e beta-1,6 glucans.(1999). J. Bacteriol., 181:7070-7079.
(64) Ram A. F. J., Kapteyn J. C., Montijin R. C., Caro L. M. P., Douwes J. E., Baginsky W., Mazur P., Van den Ende M. e Klis F. M. Loss of the plasma membrane protein Gas1p in S.cerevisiae. (1998). J. Bacteriol., 180:1-7.
(65) Nakazawa T., Horiuchi H., Ohta A. e Takagi M. Isolation and characterization of EPD1, an essential gene for pseudohyphal growth of a dimorphic yeast, Candida maltosa. (1998). J. Bacteriol., 180:2079-2086.
(66) Davies G. J., Mackenzie L., Varrot A., Dauter M., Marek Brzozowski A., Schulein M. e Withers S. G. Snapshots along an enzymatic reaction coordinate: analysis of a retaining beta-glycoside hydrolase. (1998). Biochemistry, 37 (34):11707-11713.
(67) F. de Bernardis, A. Cassone et al, The pH of the host niche controls gene expression in and virulence of C.albicans. Infect. Immunology (1998),66 :3317-3325.
(68) M.A. Ghannoum, B. Spellberg et al, Reduced virulence of C.albicans PHR1 mutants. Infect. Immun. (1995),63 :4528-4530.
(69) B. Maresca, J. Bennet et al, Molecular approches to identify novel targets for future developments. J.Med.Vet.Mycol. (1994),32:287-298.
(70) M. Weig, K. Haynes et al,A GAS-like gene family in the pathogenic fungus Candida glabrata(2001), Microbiol.,147 :2007-2019.
(71) S.M. Saporito, C.E. Birse et al, PHR1, a pH regulated gene of C.albicans., Mol. Cell. Biol. (1995),15:601-613.
(72) Cregg J. M., Tschopp J. F., Stillman C., Siegel R., Akong M., Craig W. S., Buckholz R. G., Madden K. N., Kellaris P. A., Davis G R., Smiley B. L., Cruze J., Torregrossa R., Velicelebi G. e Thill G. P. Expression of the lacZ gene from two methanol-regulated promoters in Pichia pastoris. (1987). Bio/Technology, 5 :479-485.
(73) P. Tomme, A. Boraston, et al., Affinity gel electrophoresis for the identification and caracterization of soluble sugar binding by CBM.(2000) Enzyme and Microbial Technology, 27 :453-458.
(74) C.Carotti, E.Ragni, O.Palomares et al., Caracterization of recombinant forms of the yeast Gas1p and identification of residues essential for GlutD activity and folding. (2004) Eur. J.Biochem. 271 :3635-3645.
(75) A.Perczel, M. Hollosi et al. Convex-constraint analysis: a natural deconvolution of circular dichroism curves of proteins. (1991). Prot. Eng.,4:669-679.

Vedi anche:,M1

Il dott. Paolo Greco del Dipartimento di Chimica Farmaceutica e Tossicologica dell’Universita’ Federico II di Napoli ha effettuato delle ricerche interessanti.

Se vuoi conoscere il tuo stato di Benessere e migliorarlo con queste speciali apparecchiature modernissime,  che neppure gli ospedali hanno, prenota via mail la consulenza QUI. Esso permette anche di analizzare qualsiasi prodotto esistente e la sua compatibilita' o meno, con il soggetto analizzato
 vedi anche: Medicina Quantistica
 Quindi se volete fare un Test di Bioelettronica (test di controllo del livello di Salute_benessere)
scrivete QUI:

Ecco un  metodo utile per mantenere e/o recuperare la Salute
Metodo MC
in sintesi si basa su tre fattori primari per ottenere risultati di eccellenza. Serve per disintossicare, deparassitare ed aiutare il ripristino della flora batterica autoctona, alterata per vari fattori: Vitamina K1, Vaccini, Farmaci, acque inquinate, cibi industriali intossicati da agricoltura chimica, ecc.
- Primo tra tutti la selezione e la qualità dei prodotti
- Secondo la compatibilità e il valore sinergico dei prodotti con il soggetto che li deve utilizzare
- Terzo il monitoraggio dei prodotti con test di contrazione muscolare (mediante un controllo
Kinesiologico personalizzato), per valutare l'utilizzo ideale delle sostanze all'interno di protocolli certificati.
- Vanta risultati che sfiorano il 100%.
Tutto questo può sembrare una banalità ma nasconde una selezione ed uno studio di anni con l'ausilio di Professionisti di altissimo livello.
Poi un altro contributo essenziale lo hanno portato la Passione per la materia, l'Amore per il Prossimo, il desiderio di raggiungere l'Eccellenza.

Metodo MC continua a selezionare prodotti, tecniche e Professionisti per continuare a migliorarsi ed essere sempre piu' di supporto per tutti i bisognosi.
Per visionare il tutto imparare ad utilizzarlo ed accedere all'acquisto del Metodo MC: clicca subito QUI:
MetodoMC da utilizzare ogni giorno per il periodo indicato:
- Link per acquistare i loro prodotti: